Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto M Martelli

Showing results (71-80 of 213) with videos related to

Pageof 22
Sort By:
Toxicology|June 2, 2009
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell linesLisa Bregoli, Francesca Chiarini, Andrea Gambarelli, et al.
Cellular Signalling|December 19, 2001
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphateLuca M Neri, Roberta Bortul, Giovanna Tabellini, et al.
Oncotarget|May 9, 2012
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatmentAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Cellular Signalling|July 24, 2002
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1Giovanna Tabellini, Roberta Bortul, Michela Aluigi, et al.
Journal of Cellular Physiology|August 19, 2004
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cellsGiovanna Tabellini, Alessandra Cappellini, Pier Luigi Tazzari, et al.
Biochimica Et Biophysica Acta|October 7, 2014
Autophagy in acute leukemias: a double-edged sword with important therapeutic implicationsCecilia Evangelisti, Camilla Evangelisti, Francesca Chiarini, et al.
Journal of Cellular Biochemistry|September 5, 2002
Flow cytometric detection of total and serine 473 phosphorylated AktPier Luigi Tazzari, Alessandra Cappellini, Roberta Bortul, et al.
British Journal of Haematology|August 4, 2004
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathwayGiovanna Tabellini, Pier Luigi Tazzari, Roberta Bortul, et al.
Oncotarget|November 9, 2016
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic LeukemiaCarolina Simioni, Simona Ultimo, Alberto M Martelli, et al.
Histology and Histopathology|March 19, 2010
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesisAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Pageof 22

Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
Toxicology|June 2, 2009
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell linesLisa Bregoli, Francesca Chiarini, Andrea Gambarelli, et al.
Cellular Signalling|December 19, 2001
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphateLuca M Neri, Roberta Bortul, Giovanna Tabellini, et al.
Oncotarget|May 9, 2012
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatmentAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Cellular Signalling|July 24, 2002
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1Giovanna Tabellini, Roberta Bortul, Michela Aluigi, et al.
Journal of Cellular Physiology|August 19, 2004
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cellsGiovanna Tabellini, Alessandra Cappellini, Pier Luigi Tazzari, et al.
Biochimica Et Biophysica Acta|October 7, 2014
Autophagy in acute leukemias: a double-edged sword with important therapeutic implicationsCecilia Evangelisti, Camilla Evangelisti, Francesca Chiarini, et al.
Journal of Cellular Biochemistry|September 5, 2002
Flow cytometric detection of total and serine 473 phosphorylated AktPier Luigi Tazzari, Alessandra Cappellini, Roberta Bortul, et al.
British Journal of Haematology|August 4, 2004
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathwayGiovanna Tabellini, Pier Luigi Tazzari, Roberta Bortul, et al.
Oncotarget|November 9, 2016
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic LeukemiaCarolina Simioni, Simona Ultimo, Alberto M Martelli, et al.
Histology and Histopathology|March 19, 2010
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesisAlberto M Martelli, Francesca Chiarini, Camilla Evangelisti, et al.
Pageof 22